Abiopharma

News list

Keohane Sean D 🟡 adjusted position in 2.8K shares (1 derivative) of CABOT CORP (CBT) at $85.50 Transaction Date: Aug 24, 2026 | Filing ID: 367204

Full text

News bot Aug. 26, 2026, 6:43 p.m.
🔍 Keohane Sean D (Executive)

Company: CABOT CORP (CBT)

Report Date: 2026-08-24
Transaction Summary:
- Total transactions: 4
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 5,558
- Total shares sold: 2,779
- Total shares held: 14,264
Detailed Transactions and Holdings:
- Acquired 2,779 shares of Common Stock at $50.0 per share (Direct)
  Date: 2026-08-24 | Code: M | equity_swap_involved: false | shares_owned_after: 291,652.00 | transaction_form_type: 4
- Sold 2,779 shares of Common Stock at $85.5 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: false | shares_owned_after: 288,873.00 | transaction_form_type: 4
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-24 | Code: H | nature_of_ownership: Through the Trustee for the Corporation's 401(k) Plan | shares_owned_after: 14,263.74
- Acquired 2,779 shares of Employee Stock Option (Right to Buy) at $50.0 per share (Derivative)
  Date: 2026-08-24 | Code: M | Expires: 2028-11-08 | equity_swap_involved: false | shares_owned_after: 134,895.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: 137,674 shares were subject to the option. The option vested over a three year period as follows: 30% on November 10, 2018, 30% on November 10, 2019, and 40% on November 10, 2020.